Characterization of an IncFII Plasmid Encoding NDM-1 from Escherichia coli ST131
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characterization of an IncFII Plasmid Encoding NDM-1 from Escherichia coli ST131
Authors
Keywords
-
Journal
PLoS One
Volume 7, Issue 4, Pages e34752
Publisher
Public Library of Science (PLoS)
Online
2012-04-13
DOI
10.1371/journal.pone.0034752
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evolution of IncA/CblaCMY-2-Carrying Plasmids by Acquisition of theblaNDM-1Carbapenemase Gene
- (2011) Alessandra Carattoli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tn125-Related Acquisition ofblaNDM-Like Genes in Acinetobacter baumannii
- (2011) Laurent Poirel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- International Transfer of NDM-1-ProducingKlebsiella pneumoniaefrom Iraq to France
- (2011) Laurent Poirel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetic Features ofblaNDM-1-Positive Enterobacteriaceae
- (2011) Laurent Poirel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence of NDM-1 Metallo-β-Lactamase inPseudomonas aeruginosaClinical Isolates from Serbia
- (2011) Branko Jovcic et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Analysis of the Resistome of a Multidrug-Resistant NDM-1-Producing Escherichia coli Strain by High-Throughput Genome Sequencing
- (2011) Laurent Poirel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007
- (2011) Yvonne Pfeifer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence of NDM-1-producing Acinetobacter baumannii in China
- (2011) Y. Chen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Balkan NDM-1: escape or transplant?
- (2011) David M Livermore et al. LANCET INFECTIOUS DISEASES
- Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study
- (2011) Timothy R Walsh et al. LANCET INFECTIOUS DISEASES
- Complete Sequencing of pNDM-HK Encoding NDM-1 Carbapenemase from a Multidrug-Resistant Escherichia coli Strain Isolated in Hong Kong
- (2011) Pak Leung Ho et al. PLoS One
- Complete Sequencing of the blaNDM-1-Positive IncA/C Plasmid from Escherichia coli ST38 Isolate Suggests a Possible Origin from Plant Pathogens
- (2011) Tsuyoshi Sekizuka et al. PLoS One
- The emerging NDM carbapenemases
- (2011) Patrice Nordmann et al. TRENDS IN MICROBIOLOGY
- Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India
- (2010) K. Karthikeyan et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- NDM-1-producing Klebsiella pneumoniae isolated in the Sultanate of Oman
- (2010) L. Poirel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain
- (2010) B. A. Rogers et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Global spread of New Delhi metallo-β-lactamase 1
- (2010) Laurent Poirel et al. LANCET INFECTIOUS DISEASES
- Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
- (2010) Karthikeyan K Kumarasamy et al. LANCET INFECTIOUS DISEASES
- Complete Nucleotide Sequences of Plasmids pEK204, pEK499, and pEK516, Encoding CTX-M Enzymes in Three Major Escherichia coli Lineages from the United Kingdom, All Belonging to the International O25:H4-ST131 Clone
- (2009) N. Woodford et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Resistance Plasmid Families in Enterobacteriaceae
- (2009) A. Carattoli ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Velvet: Algorithms for de novo short read assembly using de Bruijn graphs
- (2008) D. R. Zerbino et al. GENOME RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started